Buchwald Peter
Department of Molecular and Cellular Pharmacology, Miami, FL, United States.
Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
Front Pharmacol. 2025 Apr 8;16:1541872. doi: 10.3389/fphar.2025.1541872. eCollection 2025.
Concentration-response relationships connecting the concentration of ligands to the responses they produce are central to pharmacology in general and form the core of quantitative pharmacology. While typically they can be well-described by hyperbolic functions (sigmoid on commonly used semi-log scales) and characterized by half-maximal concentrations values (EC), their connection to receptor occupancy, characterized in a similar manner by the equilibrium dissociation constant , can be complex due to the intermixing of the effects from occupancy-induced activation with those from partial agonism, constitutive activity, and pathway-specific signal amplification. Here, it is proposed that, as long as both occupancy and response follow such typical concentration-dependencies, signal amplification can be quantified using the gain parameter = = /EC measured for full agonists. This is similar to the gain parameter used in electronics (e.g., = / for voltage). On customarily used semi-log representations, log corresponds to the horizontal shift between the response and occupancy curves, log -logEC, the presence of which (i.e., > EC) is generally considered as evidence for the existence of "" or "". The latter is a misnomer that should be avoided since even if there are excess receptors, there is no special pool of receptors "not required for ordinary use" as would imply. For partial agonists, the = /EC shift is smaller than for full agonists as not all occupied receptors are active. The gain parameter (full agonist /EC) corresponds to the gain parameter of the SABRE receptor model, which includes parameters for Signal Amplification (), Binding affinity ( ), and Receptor-activation Efficacy (); for partial agonists ( < 1), SABRE predicts a corresponding shift of = -+1.
将配体浓度与其产生的反应联系起来的浓度-反应关系是一般药理学的核心,也是定量药理学的核心。虽然通常它们可以用双曲线函数(在常用的半对数尺度上呈S形)很好地描述,并以半数最大浓度值(EC)为特征,但它们与受体占有率的联系,以平衡解离常数类似的方式表征,可能会很复杂,因为占据诱导激活的效应与部分激动剂、组成性活性和途径特异性信号放大的效应相互混合。在此,有人提出,只要占有率和反应都遵循这种典型的浓度依赖性,信号放大就可以使用为完全激动剂测量的增益参数 = = /EC来量化。这类似于电子学中使用的增益参数(例如, = / 用于电压)。在常用的半对数表示中,log 对应于反应曲线和占有率曲线之间的水平位移,log -logEC,其存在(即 > EC)通常被视为存在“”或“”的证据。后者是一个不恰当的名称,应该避免,因为即使有过量的受体,也不存在如 所暗示的“普通使用不需要的”特殊受体池。对于部分激动剂, = /EC的位移比完全激动剂小,因为并非所有被占据的受体都是活跃的。 增益参数(完全激动剂 /EC)对应于SABRE受体模型的 增益参数,该模型包括信号放大()、结合亲和力( )和受体激活效能()的参数;对于部分激动剂( < 1),SABRE预测相应的位移为 = -+1。